Metropolis Healthcare’s Genomics Centre Analyzed
Metropolis Healthcare has opened a new, powerful Genomics Centre. This centre builds on years of work in genetics and puts advanced technology directly to work for patients. It’s designed to give doctors clear information about a patient’s genes to help them make the best treatment decisions.
Key Points
- New Centre focuses on genomics for better healthcare outcomes.
- Integrates multiple labs for national genomics referral capacity.
- Utilizes Illumina’s NovaSeq X for rapid, high-volume sequencing.
- Offers comprehensive genomic data analysis and clinical expertise.
- Supports multi-disciplinary teams for actionable genomic insights.
- Expands genetic sequencing speed and accuracy dramatically.
The new centre started with Metropolis’s existing strengths in precision oncology, particularly through its lab in Mumbai. They added Core Diagnostics’ genomics lab in Delhi, now working as a single, high-quality national facility. This means they can do a wide range of genetic tests – called NGS assays – and understand what the results mean.
At the heart of the Centre is a special machine called the Illumina NovaSeq X Series. This machine can read a person’s DNA incredibly quickly and accurately. It can even read more than 20,000 whole genomes each year, which is far faster than older machines. This speed is key for making discoveries quickly.
To make sure the results are useful, the Centre has expert teams including molecular pathologists, genetic scientists, and counselors. They work together to turn complicated genetic information into simple, clear advice for doctors and patients. This means doctors can use the information to choose the best treatments.
Essentially, this new genomics centre is about speeding up and improving how we understand and use a person’s genes to fight disease and improve health.
Understanding a patient’s genetic makeup unlocks personalized and effective medical treatments.
